SelectQuote Q1 FY2027 slides: AI drives margins as revenue declines

SelectQuote (SLQT) reported Q1 FY2027 earnings with revenue declining 15% YoY to $280M, missing estimates, but beat EPS expectations. Adjusted EBITDA improved $15M YoY to -$17M. AI-driven efficiencies boosted margins, with Healthcare Services EBITDA up 56%. Management maintained guidance for $60M+ operating cash flow in FY2027. Stock surged 28.95% premarket to $0.529.

Original reporting
Published Nov 4, 2026, 3:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SLQT
Bearish
high confidence
Mentioned
$SLQT
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SLQTBearishHigh
01

Why it matters

The earnings beat and strong pre‑market rally suggest the market values the AI‑driven margin improvements, but revenue pressure remains a concern.

02

Market read

SelectQuote's earnings surprise and AI‑focused strategy create a short‑term trading opportunity while signaling longer‑term operational shifts in the insurance sector.

03

What to watch

Potential regulatory scrutiny of AI usage in underwriting and the impact of the Inflation Reduction Act on healthcare revenue.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

SelectQuote is a U.S. insurance distribution platform that recently invested heavily in AI for call transcription and enrollment automation.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

SelectQuote reported Q1 FY2027 adjusted EPS beat (-$0.21 vs -$0.34) and revenue miss, sending the stock up 28.95% pre‑market.

Expected impact

likely upward pressure as traders price in the earnings beat and AI‑driven margin improvements.

Evidence & confidence

The surprise EPS beat and 28% pre‑market rally indicate fresh buying interest; margin guidance supports continued upside.

Market effects

AI‑enabled efficiency gains in insurance distribution may prompt peers to accelerate automation initiatives.

U.S. small‑cap insurance stocks could see modest spillover buying.

Limited to U.S. equity markets; no broader macro effect.

Counterpoint

Revenue decline and reliance on AI could expose the company to execution risk if cost savings fall short.

Key entities

  • Tim Danker

    CEO who highlighted AI impact on margins.

  • Ryan Clement

    CFO who discussed cash‑flow guidance and potential dividend.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMedAI 8/10

SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMed

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

$SLQTMedAI 8/10

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.